India began vaccinating 15 to 18 year olds from January 3 using indigenously-developed Bharat Biotech’s Covaxin
Covid panel chief Dr NK Arora explained the possible benefits of vaccinating children in the 15-18 age group, saying these people may get infected at schools...
The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six...
On November 2, the centre launched 'Har Ghar Dastak' campaign to complete maximum single dose and second dose adult COVID-19 vaccination
All injectable vaccines will only prevent the hospitalisation and not the disease, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella as he urged...
Recently, the Subject Expert Committee had given a recommendation to the DCGI for the use of Bharat Biotech's Covaxin Covid-19 vaccine for the beneficiaries aged between...
Zydus Cadila's ZyCov-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above in August
A new study suggest that a third dose of Covid vaccine can reduce risk of Covid-related hospitalisation by 93 per cent
Researchers led by Imperial College London, UK, found that COVID-19 vaccinated people clear the infection more quickly, but the peak viral load among them is similar...
Delivering a keynote address on 'National security preparedness in the age of disasters and pandemics’, Dr Soumya Swaminathan called for the need to invest in the...
An advisory committee to the Indian regulator recommended emergency use of Bharat Biotech's COVID-19 shot for children aged 2 to 18. Approval from Drugs Control General...
Apollo Hospitals group to provide free vaccines for children with co-morbidities once they get approval for the same from the government.
